Status | Study |
Active, not recruiting |
Study Name: Phase 2 Study of NGM282 in Patients With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2016-02-29 Interventions: Biological: NGM282 Other: Placebo |
Recruiting |
Study Name: PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Subjects With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2016-01-08 Interventions: Drug: Cenicriviroc 150 mg One tablet of CVC 150 mg once daily taken with food in the morning |
Recruiting |
Study Name: Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy for PSC Biliary Strictures Condition: Primary Sclerosing Cholangitis Date: 2015-12-09 Interventions: Device: probe based confocal laser endomicroscopy real-time, microscopic imaging of tissue at the cellul |
Recruiting |
Study Name: Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients Condition: Primary Sclerosing Cholangitis Date: 2015-10-31 Interventions: Drug: Vancomycin Vancomycin fo |
Completed |
Study Name: Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC) Condition: Primary Sclerosing Cholangitis Date: 2014-09-05 |
Recruiting |
Study Name: A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2014-09-04 Interventions: Drug: BTT1023 IV (in the vein) Investigational Medicinal Product (IMP) |
Active, not recruiting |
Study Name: Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC) Condition: Primary Sclerosing Cholangitis (PSC) Date: 2014-06-26 Interventions: Drug: OCA Drug: Placebo |
Completed |
Study Name: Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis (PSC) Date: 2014-02-11 Interventions: Drug: LUM001 LUM001 oral dose |
Active, not recruiting |
Study Name: Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects Condition: Primary Sclerosing Cholangitis Date: 2013-02-21 Interventions: Drug: Oral Vancomycin Other Name: Vancocin |
Completed |
Study Name: Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis Condition: Primary Sclerosing Cholangitis Date: 2012-12-19 Interventions: Drug: norUDCA Comparison of di |